Perceptions of COVID-19 vaccine among different adult age group populations in Northern Uganda: a cross-sectional study

D. Kitara, Steven Baguma, C. Okot, D. Acullu, Denis Ochula, Pamela A Okot, P. Odong, S. G. Okot, F. Pebolo, F. W. D. Oyat, E. Ikoona, N. O. Alema, J. N. Oloya, J. Aloyo, Lawence Oballim
{"title":"Perceptions of COVID-19 vaccine among different adult age group populations in Northern Uganda: a cross-sectional study","authors":"D. Kitara, Steven Baguma, C. Okot, D. Acullu, Denis Ochula, Pamela A Okot, P. Odong, S. G. Okot, F. Pebolo, F. W. D. Oyat, E. Ikoona, N. O. Alema, J. N. Oloya, J. Aloyo, Lawence Oballim","doi":"10.29392/001c.74443","DOIUrl":null,"url":null,"abstract":"At the time when COVID-19 was declared a pandemic in March 2020, its spread in the African continent was slow. However, confirmed cases of the virus have since risen steadily over the years in the African continent for many reasons. This study aimed to determine factors associated with perceptions of COVID-19 vaccines among adult age-group populations in northern Uganda. We conducted this study as part of a larger study to determine factors associated with COVID-19 vaccine hesitancy/acceptance among 723 adult age-group populations selected by stratified and systematic sampling approaches from northern Uganda. We used a questionnaire with an internal validity of Cronbach’s α= 0.772. A five-point Likert scale, with responses categorized as strongly agree “SA”, agree “A”, neutral “N”, disagree “DA”, and strongly disagree “SD”, was used to assess participants’ perceptions on COVID-19 vaccines. A multivariable regression analysis was conducted with P-value set at <0.05. Overall, 723 participated in the study with a mean age of 31.4 years (standard deviation, SD, +10.1). The majority 54.5% (n=394) were males. There were no significant differences in perceptions of COVID-19 vaccines among age-group populations (adjusted odds ratio, aOR=0.99, 95% confidence interval, CI=0.98-1.01). Key finding include: (i) it was important to take a COVID-19 vaccine (aOR=1.02, 95% CI=1.00-1.04); (ii) vaccines have unlikely unforeseen side effects (aOR=0.98, 95% CI=0.97-0.99); (iii) vaccines were unlikely being promoted for commercial gains (aOR=0.98, 95% CI=0.97-0.99); and children could take COVID-19 vaccines (aOR=1.02, 95% CI=1.00-1.03). Stratified by age-groups, the 20–29-year-old perceived COVID-19 vaccines developed in Uganda as unlikely safe and effective (aOR=0.59, 95% CI=0.35-0.97), and COVID-19 vaccines have likely unforeseen side-effects (aOR=2.1, 95% CI=1.3-3.6). While the ≥50-year-old group perceived that COVID-19 vaccines were unlikely being promoted for commercial gains (aOR=0.2, 95% CI=0.1-0.6). There were no substantial differences in perceptions on COVID-19 vaccines in adult age-group populations in northern Uganda. The determinants of COVID-19 vaccine perceptions were its importance against the virus; vaccines have unlikely unforeseen side-effects, and children could take it. Stratified by age-groups, some age-groups perceived COVID-19 vaccines developed in Uganda as unlikely safe and unlikely being promoted for commercial gains.","PeriodicalId":73759,"journal":{"name":"Journal of global health reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of global health reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29392/001c.74443","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

At the time when COVID-19 was declared a pandemic in March 2020, its spread in the African continent was slow. However, confirmed cases of the virus have since risen steadily over the years in the African continent for many reasons. This study aimed to determine factors associated with perceptions of COVID-19 vaccines among adult age-group populations in northern Uganda. We conducted this study as part of a larger study to determine factors associated with COVID-19 vaccine hesitancy/acceptance among 723 adult age-group populations selected by stratified and systematic sampling approaches from northern Uganda. We used a questionnaire with an internal validity of Cronbach’s α= 0.772. A five-point Likert scale, with responses categorized as strongly agree “SA”, agree “A”, neutral “N”, disagree “DA”, and strongly disagree “SD”, was used to assess participants’ perceptions on COVID-19 vaccines. A multivariable regression analysis was conducted with P-value set at <0.05. Overall, 723 participated in the study with a mean age of 31.4 years (standard deviation, SD, +10.1). The majority 54.5% (n=394) were males. There were no significant differences in perceptions of COVID-19 vaccines among age-group populations (adjusted odds ratio, aOR=0.99, 95% confidence interval, CI=0.98-1.01). Key finding include: (i) it was important to take a COVID-19 vaccine (aOR=1.02, 95% CI=1.00-1.04); (ii) vaccines have unlikely unforeseen side effects (aOR=0.98, 95% CI=0.97-0.99); (iii) vaccines were unlikely being promoted for commercial gains (aOR=0.98, 95% CI=0.97-0.99); and children could take COVID-19 vaccines (aOR=1.02, 95% CI=1.00-1.03). Stratified by age-groups, the 20–29-year-old perceived COVID-19 vaccines developed in Uganda as unlikely safe and effective (aOR=0.59, 95% CI=0.35-0.97), and COVID-19 vaccines have likely unforeseen side-effects (aOR=2.1, 95% CI=1.3-3.6). While the ≥50-year-old group perceived that COVID-19 vaccines were unlikely being promoted for commercial gains (aOR=0.2, 95% CI=0.1-0.6). There were no substantial differences in perceptions on COVID-19 vaccines in adult age-group populations in northern Uganda. The determinants of COVID-19 vaccine perceptions were its importance against the virus; vaccines have unlikely unforeseen side-effects, and children could take it. Stratified by age-groups, some age-groups perceived COVID-19 vaccines developed in Uganda as unlikely safe and unlikely being promoted for commercial gains.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乌干达北部不同成年年龄组人群对COVID-19疫苗的看法:一项横断面研究
当新冠肺炎于2020年3月被宣布为大流行时,它在非洲大陆的传播缓慢。然而,由于多种原因,非洲大陆的确诊病例多年来稳步上升。本研究旨在确定乌干达北部成年人群对新冠肺炎疫苗认知的相关因素。我们进行了这项研究,作为一项更大研究的一部分,以确定通过分层和系统抽样方法从乌干达北部选择的723名成年年龄组人群中与新冠肺炎疫苗犹豫/接受相关的因素。我们使用了一份内部有效性为Cronbachα=0.772的问卷。使用五点Likert量表评估参与者对新冠肺炎疫苗的看法,其中回答分为强烈同意“SA”、同意“A”、中立“N”、不同意“DA”和强烈不同意“SD”。进行多变量回归分析,P值设置为<0.05。总的来说,723人参与了这项研究,平均年龄为31.4岁(标准差,SD,+10.1)。大多数54.5%(n=394)是男性。年龄组人群对新冠肺炎疫苗的认知没有显著差异(调整后的比值比,aOR=0.99,95%置信区间,CI=0.98-0.01)。关键发现包括:(i)接种新冠肺炎疫苗很重要(aOR=1.02,95%CI=1.00-1.04);(ii)疫苗具有不太可能的意外副作用(aOR=0.98,95%CI=0.97-0.99);(iii)疫苗不太可能被推广用于商业收益(aOR=0.98,95%CI=0.97-0.99);儿童可以接种新冠肺炎疫苗(aOR=1.02,95%CI=1.00-1.03)。按年龄组划分,20-29岁的乌干达人认为新冠肺炎疫苗不太安全有效(aOR=0.59,95%CI=0.35-0.97),新冠肺炎疫苗可能会产生不可预见的副作用(aOR=2.1,95%CI=1.3-3.6)。而≥50岁的人群认为新冠肺炎疫苗不太可能被推广用于商业收益(aOR=0.2,95%CI=0.1-0.6)。乌干达北部成年人群对新冠肺炎疫苗的看法没有显著差异。新冠肺炎疫苗认知的决定因素是其对抗病毒的重要性;疫苗有不太可能出现的意外副作用,儿童可能会服用。按年龄组划分,一些年龄组认为乌干达开发的新冠肺炎疫苗不太可能安全,也不太可能被推广用于商业目的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
0
审稿时长
16 weeks
期刊最新文献
Implementation of Nigeria’s surgical plan: leveraging media engagement for cleft lip and palate to drive advocacy for access to surgical healthcare Digital health interventions in primary care in low- and middle-income countries: a systematic scoping review protocol Developing conceptual framework and methodological considerations in community-supported chronic disease management Using spirometry for screening and diagnosis of chronic respiratory diseases in primary health care: findings from a community health project in rural India Maternal health in cities: analysis of institutional maternal mortality and health system bottlenecks in Kampala City Uganda, 2016-2021
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1